В. В. Бредер

机构：Russian Cancer Research Center NN Blokhin, Ministry of Health of the Russian Federation, Kementerian Kesehatan Republik Indonesia, National Medical Research Center of Cardiology · ORCID：0000-0002-6244-4294

发表论文 246 篇 · 总被引 22263 次 · h-index 32

代表论文

• Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC (2025 · Journal of Hepatology · 被引 153)
• Adjuvant pembrolizumab for participants with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation: The phase 3 keynote-937 study. (2026 · Journal of Clinical Oncology · 被引 13)
• Злокачественные опухоли печени и желчевыводящей системы (2025 · Malignant tumours · 被引 2)
• 1047P Pembrolizumab (Pembro) monotherapy for locally advanced or metastatic non–small-cell lung cancer (NSCLC): 10-year outcomes from clinical trials (2025 · Annals of Oncology · 被引 1)
• Subsequent anticancer therapy analysis of the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (2025 · Zeitschrift für Gastroenterologie · 被引 1)
• Real-World Treatment Patterns and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma: Results from the OREIOS Study (2025 · Liver Cancer · 被引 1)